Two in five Americans say they don't want a COVID-19 vaccine, which is a problem. Finding out what Americans do want from a vaccine might help.
Jan. 13, 2021 • ~9 min
covid-19 coronavirus vaccines herd-immunity covid-19-vaccine vaccine-safety vaccine-hesitancy moderna-vaccine pfizer-vaccine
The shipment of goods to suppliers has become technologically sophisticated. Delays in getting out the COVID-19 vaccine to people show that the breakdowns come down to something more basic.
Jan. 8, 2021 • ~10 min
covid-19 coronavirus covid-19-vaccines moderna-vaccine pfizer-vaccine vaccine-distribution
If I have allergies, should I get the coronavirus vaccine? An expert answers this and other questions
A serious allergic reaction was reported in a health care worker in Alaska after she received the COVID-19 vaccine. Does this mean that people with allergies need to be concerned? An expert answers.
Dec. 18, 2020 • ~5 min
covid-19 covid-19-vaccine emergency-use-authorization pfizer-vaccine
The top scientific breakthrough for 2020 was understanding SARS-CoV-2 and how it causes COVID-19 – and then developing multiple vaccines
The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
Dec. 17, 2020 • ~11 min
innovation genome covid-19 immune-system pandemic vaccines sars-cov-2 remdesivir drug-development monoclonal-antibodies astrazeneca pfizerbiontech-vaccine moderna-vaccine pfizer-vaccine
As the coronavirus rages, a vaccine finally is available for certain groups of people and will soon be ready for other groups. But there are plenty of questions. A doctor answers five here.
Dec. 15, 2020 • ~4 min
covid-19 coronavirus coronavirus-vaccine coronavirus-transmission pfizer-vaccine
Oxford-AstraZeneca vaccine is cheaper than Pfizer's and Moderna's and doesn't require supercold temperature
There is now a third vaccine that prevents COVID-19 infections. It isn't quite as effective as the other two vaccines but it has advantages that may make it the frontrunner.
Nov. 24, 2020 • ~9 min
covid-19 immune-system pandemic vaccines sars-cov-2 antibody university-of-oxford astrazeneca covid-19-vaccines pfizerbiontech-vaccine moderna-vaccine pfizer-vaccine